Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Praxis Precision Medicines (PRAX) Depreciation & Amortization (CF): 2022-2025

Historic Depreciation & Amortization (CF) for Praxis Precision Medicines (PRAX) over the last 4 years, with Sep 2025 value amounting to $19,000.

  • Praxis Precision Medicines' Depreciation & Amortization (CF) fell 79.35% to $19,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $201,000, marking a year-over-year decrease of 52.37%. This contributed to the annual value of $400,000 for FY2024, which is 7.41% down from last year.
  • Latest data reveals that Praxis Precision Medicines reported Depreciation & Amortization (CF) of $19,000 as of Q3 2025, which was down 58.70% from $46,000 recorded in Q2 2025.
  • Praxis Precision Medicines' 5-year Depreciation & Amortization (CF) high stood at $119,000 for Q2 2022, and its period low was $19,000 during Q3 2025.
  • Moreover, its 3-year median value for Depreciation & Amortization (CF) was $106,000 (2023), whereas its average is $85,818.
  • As far as peak fluctuations go, Praxis Precision Medicines' Depreciation & Amortization (CF) climbed by 13.98% in 2023, and later slumped by 79.35% in 2025.
  • Quarterly analysis of 4 years shows Praxis Precision Medicines' Depreciation & Amortization (CF) stood at $105,000 in 2022, then increased by 5.71% to $111,000 in 2023, then fell by 19.82% to $89,000 in 2024, then plummeted by 79.35% to $19,000 in 2025.
  • Its last three reported values are $19,000 in Q3 2025, $46,000 for Q2 2025, and $47,000 during Q1 2025.